Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGelion Regulatory News (GELN)

Share Price Information for Gelion (GELN)

Share Price is delayed by 15 minutes
Get Live Data
19.00    -0.25 (-1.30%)
Bid:
18.00
Ask:
20.00
Spread: 2.00 (11.111%)
Market Cap: £43.59m
GELN Live PriceLast checked at - London Stock Exchange

Intraday Gelion Share Chart

Block Admission Return

27 Jan 2026 08:02

RNS Number : 5187Q
Gelion PLC
27 January 2026
 

27 January 2026

Gelion plc

("Gelion" or the "Company")

Block Admission Return

The Company provides the following update in accordance with Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements:

 

a

Name of company

 

Gelion plc

b

Name of scheme

 

Gelion plc scheme: Shares

 

Existing Share Option Plan 8,100,000

 

c

Period of return (from/ to)

 

26 July 2025 to 26 January 2026

d

Number and Class of Securities not issued at the start of the period under the scheme 

7,872,940 ordinary shares of 0.1p each

e

Additional listing

Nil

f

Number of securities issued under the scheme during the period

 

Shares

Existing Share Option Plan 69,673

g

Balance under the scheme of securities not yet issued at the end of the period

 

Shares

Existing Share Option Plan 7,803,267

 

 

h

Number and class of securities originally admitted and the date of admission

8,100,000 ordinary shares of 0.1p each

 

i

Contact name - Company 

Telephone number

 

Contact name - Strand Hanson Limited

Telephone number

Amit Gupta

+44 (0) 20 3405 0205

 

Christopher Raggett 

+44 (0) 20 7409 3494

 

CONTACTS

Gelion plc

John Wood, CEO

Amit Gupta, CFO

 

via Alma

Strand Hanson Limited (Nominated and Financial Adviser)

Christopher Raggett / Rob Patrick / Harry Marshall

 

Oberon Capital (Joint Broker)

Nick Lovering / Mike Seabrook / Adam Pollock

+44 (0) 20 7409 3494

 

+44 (0) 20 3179 5300

 

 

Allenby Capital Limited (Joint Broker)

Jos Pinnington / Lauren Wright (Sales and Corporate Broking)

Alex Brearley / Ashur Joseph (Corporate Finance)

 

 

 

+44 (0) 20 3328 5656

Alma Strategic Communications (Financial PR Adviser)

Justine James / Hannah Campbell / Rose Docherty

 

+44 (0) 20 3405 0205

gelion@almastrategic.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAKOBKFBKKBDB
Date   Source Headline
25th Apr 202511:30 amRNSNotice of Presentation
23rd Apr 20257:00 amRNSResult of Retail Offer
22nd Apr 202510:30 amRNSExecution of Materials Testing Agreement
17th Apr 202511:45 amRNSResult of Placing and Subscription
17th Apr 20257:10 amRNSRetail Offer via BookBuild
17th Apr 20257:05 amRNSProposed Placing, Subscription & Retail Offer
17th Apr 20257:00 amRNSBreakthrough Sulfur Test Results and MTA agreed
17th Apr 20257:00 amRNSFactory Acceptance Test Complete & First Revenue
27th Mar 202512:00 pmRNSProf. Markus Antonietti Appointed as Tech Advisor
27th Mar 20257:00 amRNSStrategic Partnership with Max Planck Institute
25th Mar 20257:00 amRNSAppointment of Nominated and Financial Adviser
19th Mar 20257:00 amRNSInterim results to 31 December 2024
14th Mar 20252:00 pmRNSNotice of Results and Investor Presentation
4th Mar 20257:00 amRNSRecycling secures Phase 2 Grant & Booster Funding
26th Feb 20257:00 amRNSSuccessful Grant of three LiS Patents in the U.S.
12th Feb 20257:30 amRNSGelion’s GEN 3 Sulfur Cathode viability update
3rd Feb 202510:41 amRNSResult of GM
27th Jan 20257:00 amRNSBlock Admission Return
10th Jan 20257:00 amRNSPosting of Annual Report and Notice of GM
6th Jan 20257:00 amRNSDirector appointment - Dr Graham Cooley
3rd Jan 20257:00 amRNSDirectors' Participation in Fundraising
30th Dec 20242:51 pmRNSResult of AGM
27th Dec 20247:00 amRNSFinal results to 30 June 2024
20th Dec 20245:54 pmRNSResult of Retail Offer and Total Voting Rights
19th Dec 20247:00 amRNSResult of Placing and Subscription
18th Dec 20244:40 pmRNSRetail Offer for up to £0.15 million
18th Dec 20244:35 pmRNSProposed Placing and Retail Offer
18th Dec 20244:30 pmRNS£2.5m Australian Government Grant awarded
5th Dec 202410:31 amRNSNotice of AGM
5th Dec 202410:30 amRNSNotice of Results and Investor Presentation
13th Nov 20247:00 amRNSGelion Produces Solid-State Separator
6th Nov 20247:00 amRNSLaunch of New Website
16th Oct 20247:00 amRNSEnergy Storage Integration Solutions Launch
18th Sep 20247:30 amRNSGrant Funding and Accelerator Programme
4th Sep 20247:00 amRNSGEN 3 Lithium-Sulfur energy density milestone
15th Aug 20247:00 amRNSGEN 3 Lithium-Sulfur Battery Development Update
26th Jul 20247:00 amRNSBlock Admission Return
18th Jul 20248:49 amRNSDirector/PDMR Shareholding
15th Jul 202412:33 pmRNSDirector/PDMR Shareholding
26th Jun 20247:00 amRNSGlencore and Gelion JDA Announcement
24th Apr 20248:30 amRNSMello Investor Presentation
4th Apr 20247:00 amRNSLi-S Cell High Energy Density Milestone Achieved
27th Mar 20247:00 amRNSInterim results to 31 December 2023
20th Mar 202410:09 amRNSNotice of Results and Investor Presentation
19th Mar 20247:00 amRNSLithium-Sulfur Battery development update
5th Feb 20247:00 amRNSSenior Leadership Team Appointments
29th Jan 20247:00 amRNSBlock Admission Return
16th Jan 202411:27 amRNSResult of General Meeting
22nd Dec 202310:41 amRNSExercise of Options, Director Shareholding & TVRs
21st Dec 202312:23 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.